Dynavax Technologies Corp. (DVAX) Tumbled To A New Low After FDA Letter

Dynavax Technologies Corp. (DVAX) announced Monday morning that it has received a Complete Response Letter from the FDA regarding HEPLISAV-B.

from RTT - Before the Bell http://ift.tt/2ftO7lx
via IFTTT